A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that adult patients ...

Intelligent Scopes Corp (“ISC”), specializing in state-of-the-art image enhancement and precision AI software solutions for urology and gastroenterology, is pleased to announce that CystoSmart™ has ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Pat Finn, known for his roles in Seinfeld and The Middle, has died at age 60 after a battle with bladder cancer. Fans and ...

Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

Pat Finn, an actor best known for his roles on “Seinfeld” and “The Middle,” has died. Finn passed away Dec. 22, at age 60 of ...

The Middle alum Pat Finn’s cause of death has been revealed. “It is with profound sadness and grief that the Finn family ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

Investigators studied US trends in the diagnosis of variant histology bladder cancer using the National Cancer database.

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility,” by Astellas Pharma Inc. News release; Dec. 17, 2025.